Glen Santangelo
Stock Analyst at Barclays
(3.21)
# 1,094
Out of 5,140 analysts
114
Total ratings
51.28%
Success rate
1.73%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Overweight | $50 | $43.30 | +15.47% | 1 | Jan 12, 2026 | |
| COLL Collegium Pharmaceutical | Maintains: Overweight | $58 → $56 | $47.01 | +19.12% | 5 | Jan 9, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $29 → $40 | $31.41 | +27.35% | 6 | Jan 6, 2026 | |
| PHR Phreesia | Maintains: Overweight | $26 → $24 | $15.62 | +53.65% | 3 | Dec 16, 2025 | |
| ZTS Zoetis | Initiates: Equal-Weight | $136 | $125.08 | +8.73% | 2 | Dec 9, 2025 | |
| XERS Xeris Biopharma Holdings | Initiates: Overweight | $9 | $7.62 | +18.11% | 3 | Dec 9, 2025 | |
| VTRS Viatris | Initiates: Overweight | $15 | $13.05 | +14.94% | 5 | Dec 9, 2025 | |
| TDOC Teladoc Health | Initiates: Equal-Weight | $8.5 | $6.16 | +37.99% | 8 | Dec 9, 2025 | |
| TARS Tarsus Pharmaceuticals | Initiates: Overweight | $100 | $71.25 | +40.35% | 1 | Dec 9, 2025 | |
| TALK Talkspace | Initiates: Equal-Weight | $3.5 | $3.82 | -8.38% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $25.45 | +13.95% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $16 | $13.61 | +17.56% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $20.24 | +33.40% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $78.94 | +8.94% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $118 | $84.59 | +39.50% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $3 | $2.58 | +16.28% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $24.67 | -2.72% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $24.30 | +23.46% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $63 | $39.85 | +58.09% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $12.74 | -5.81% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $400 | $351.75 | +13.72% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $243 | $208.47 | +16.56% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8 | $6.65 | +20.30% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $85.52 | +16.93% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $26.22 | +14.42% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $13.71 | +9.41% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $35.87 | +36.60% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $5.04 | -0.79% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $170 | $169.95 | +0.03% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $7.5 | $9.59 | -21.79% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $960 | $823.25 | +16.61% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $850 | $696.46 | +22.05% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $28.89 | +66.15% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $29.56 | +72.53% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $7.76 | +1,188.66% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $63.01 | -12.71% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.30 | +1,117.39% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.54 | +2,543.17% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.38 | +1,412.61% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $81.49 | - | 3 | Mar 17, 2021 |
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $43.30
Upside: +15.47%
Collegium Pharmaceutical
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $47.01
Upside: +19.12%
Teva Pharmaceutical Industries
Jan 6, 2026
Maintains: Buy
Price Target: $29 → $40
Current: $31.41
Upside: +27.35%
Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $15.62
Upside: +53.65%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $125.08
Upside: +8.73%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.62
Upside: +18.11%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $13.05
Upside: +14.94%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $6.16
Upside: +37.99%
Tarsus Pharmaceuticals
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $71.25
Upside: +40.35%
Talkspace
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.82
Upside: -8.38%
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $25.45
Upside: +13.95%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $13.61
Upside: +17.56%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $20.24
Upside: +33.40%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $78.94
Upside: +8.94%
Dec 9, 2025
Initiates: Overweight
Price Target: $118
Current: $84.59
Upside: +39.50%
Dec 9, 2025
Initiates: Underweight
Price Target: $3
Current: $2.58
Upside: +16.28%
Dec 9, 2025
Initiates: Overweight
Price Target: $24
Current: $24.67
Upside: -2.72%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $24.30
Upside: +23.46%
Dec 9, 2025
Initiates: Overweight
Price Target: $63
Current: $39.85
Upside: +58.09%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $12.74
Upside: -5.81%
Dec 9, 2025
Initiates: Overweight
Price Target: $400
Current: $351.75
Upside: +13.72%
Dec 9, 2025
Initiates: Overweight
Price Target: $243
Current: $208.47
Upside: +16.56%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8
Current: $6.65
Upside: +20.30%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $85.52
Upside: +16.93%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $26.22
Upside: +14.42%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $13.71
Upside: +9.41%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $35.87
Upside: +36.60%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $5.04
Upside: -0.79%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $170
Current: $169.95
Upside: +0.03%
Dec 9, 2025
Initiates: Underweight
Price Target: $7.5
Current: $9.59
Upside: -21.79%
Dec 9, 2025
Initiates: Overweight
Price Target: $960
Current: $823.25
Upside: +16.61%
Dec 9, 2025
Initiates: Overweight
Price Target: $850
Current: $696.46
Upside: +22.05%
Dec 9, 2025
Initiates: Overweight
Price Target: $48
Current: $28.89
Upside: +66.15%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $29.56
Upside: +72.53%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $7.76
Upside: +1,188.66%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $63.01
Upside: -12.71%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.30
Upside: +1,117.39%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.54
Upside: +2,543.17%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.38
Upside: +1,412.61%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $81.49
Upside: -